vimarsana.com
Home
Live Updates
Viking Therapeutics' stock soars 61% premarket after company reports positive results in trial of weight-loss drug : vimarsana.com
Viking Therapeutics' stock soars 61% premarket after company reports positive results in trial of weight-loss drug : vimarsana.com
Viking Therapeutics' stock soars 61% premarket after company reports positive results in trial of weight-loss drug
Viking posted positive results from a mid-stage trial of its GLP-1 drug.
Related Keywords
,
Drug Administration ,
Therapeutics Inc ,
Viking Therapeutics ,
Article Normal ,
Biotechnology ,
Pharmaceuticals ,
Machinery ,
Agricultural Machinery ,
Health Care ,
Biopharmaceuticals ,
Specialized Drugs Medications ,
Hormone Products ,
Industrial Goods ,
Diabetes Drugs ,
Regulation Government Policy ,
Financial Performance ,
Share Price Movement Disruptions ,
New Products Services ,
Research Development ,
Corporate Industrial News ,
Products Services ,
New Product Service Testing ,
Political General News ,
Society Community ,
Diabetes ,
Physical Mental Fitness ,
Health ,
Living Lifestyle ,
Medical Conditions ,
Obesity ,
Social Issues ,
Weight Management ,
Content Types ,
Factiva Filters ,
C Amp Ampe Exclusion Filter ,
C Amp Ampe Industry News Filter ,
Viking Therapeutics Inc ,
Vktx ,
Novo Nordiskas Adr ,
Nvo ,
Novo Nordiska S ,
Dk Novo B ,
Eli Lilly Amp Co ,
Lly ,
Spx ,
S Amp Ampp 500 Index ,
Regulation ,
Government Policy ,
Share Price Movement ,
Disruptions ,
New Products ,
Services ,
Research ,
Development ,
Corporate ,
Industrial News ,
Products ,
New Product ,
Service Testing ,
Political ,
General News ,
Society ,
Community ,
Physical ,
Mental Fitness ,
Living ,
Lifestyle ,
Specialized Drugs ,
Medications ,